{"id":"iron-sucrose-iv","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Hypotension"},{"rate":"5-10","effect":"Headache"},{"rate":"3-8","effect":"Nausea"},{"rate":"2-5","effect":"Vomiting"},{"rate":"2-5","effect":"Abdominal pain"},{"rate":"2-5","effect":"Diarrhea"},{"rate":"1-3","effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL1200823","moleculeType":"Small molecule","molecularWeight":"398.14"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iron sucrose is a polynuclear iron(III) hydroxide sucrose complex that provides bioavailable iron for erythropoiesis. When administered intravenously, the complex is taken up by macrophages and transferred to transferrin for transport to bone marrow erythroid precursors, where it is incorporated into hemoglobin. This formulation reduces gastrointestinal side effects associated with oral iron and provides rapid iron repletion in patients with iron deficiency anemia, particularly those with chronic kidney disease or intolerance to oral iron.","oneSentence":"Iron sucrose delivers iron as a stable complex that is absorbed and utilized by the body to replenish iron stores and support hemoglobin synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:15.397Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients with chronic kidney disease (CKD), including those on hemodialysis and peritoneal dialysis"},{"name":"Iron deficiency anemia in non-dialysis CKD patients"},{"name":"Iron deficiency anemia in patients intolerant or unresponsive to oral iron therapy"}]},"trialDetails":[{"nctId":"NCT05385042","phase":"NA","title":"Iron and Immune Response to Vaccine (IRONMUM)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-06-18","conditions":"Pregnancy Related","enrollment":171},{"nctId":"NCT07115121","phase":"NA","title":"Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-02-02","conditions":"Anemia","enrollment":40},{"nctId":"NCT00236964","phase":"PHASE3","title":"Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2001-02-23","conditions":"Anemia","enrollment":96},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":"Iron Deficiency Anemia (IDA), Pregnancy","enrollment":60},{"nctId":"NCT05800600","phase":"PHASE2","title":"Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2023-03-15","conditions":"Anemia","enrollment":34},{"nctId":"NCT05353348","phase":"NA","title":"Effect of the Combined Programme on Perioperative Anaemia（CPPA）","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-15","conditions":"Patient Blood Management, Cardiac Surgery, Iron Deficiency Anemia","enrollment":110},{"nctId":"NCT06703411","phase":"PHASE4","title":"Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency","status":"COMPLETED","sponsor":"Cheng-Hsin General Hospital","startDate":"2023-05-01","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Hospitalization, Iron Deficiency","enrollment":76},{"nctId":"NCT06556134","phase":"PHASE4","title":"Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Hassan II - Fès","startDate":"2021-07-01","conditions":"Anemia of Chronic Kidney Disease","enrollment":27},{"nctId":"NCT06366698","phase":"PHASE3","title":"Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Arrowhead Regional Medical Center","startDate":"2023-11-21","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":900},{"nctId":"NCT06248749","phase":"PHASE3","title":"Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"University of Saskatchewan","startDate":"2024-02-29","conditions":"Anaemia in Ovarian Carcinoma","enrollment":200},{"nctId":"NCT01052779","phase":"PHASE2","title":"A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-03-01","conditions":"Iron Deficiency, Anemia, Kidney Disease","enrollment":162},{"nctId":"NCT03933813","phase":"PHASE1, PHASE2","title":"Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2019-07-29","conditions":"Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia","enrollment":9},{"nctId":"NCT05581420","phase":"NA","title":"Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2022-06-02","conditions":"Inflammatory Bowel Diseases","enrollment":152},{"nctId":"NCT01114204","phase":"PHASE3","title":"A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-08-10","conditions":"Iron Deficiency Anemia","enrollment":605},{"nctId":"NCT01227616","phase":"PHASE4","title":"Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2013-08","conditions":"Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD)","enrollment":296},{"nctId":"NCT04291690","phase":"NA","title":"The TARGET-EFT Randomized Clinical Trial","status":"COMPLETED","sponsor":"Jonathan Afilalo","startDate":"2020-03-05","conditions":"Frailty, Cardiovascular Diseases in Old Age, Geriatric Cardiology","enrollment":144},{"nctId":"NCT01414075","phase":"PHASE2","title":"Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment","status":"COMPLETED","sponsor":"Kyntra Bio","startDate":"2011-07-21","conditions":"Dialysis, Anemia","enrollment":60},{"nctId":"NCT03591406","phase":"PHASE3","title":"To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-07-03","conditions":"Iron Deficiency Anemia","enrollment":371},{"nctId":"NCT00236977","phase":"PHASE3","title":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-08","conditions":"Anemia","enrollment":182},{"nctId":"NCT02940886","phase":"PHASE3","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2016-11-08","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":1512},{"nctId":"NCT02940860","phase":"PHASE3","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2016-11-29","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia, Chronic Kidney Disease","enrollment":1538},{"nctId":"NCT04155814","phase":"PHASE1","title":"Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2019-09-19","conditions":"Bioequivalance","enrollment":196},{"nctId":"NCT04359368","phase":"","title":"Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-09-01","conditions":"Iron-deficiency, Hypersensitivity Reactions","enrollment":42},{"nctId":"NCT03508466","phase":"","title":"Mechanism of Hypersensitivity Reactions to Iron Nanomedicines","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-10-01","conditions":"Iron-deficiency","enrollment":42},{"nctId":"NCT04225728","phase":"PHASE4","title":"Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study","status":"COMPLETED","sponsor":"CN NGANOU-GNINDJIO, MD, MSc","startDate":"2017-12-01","conditions":"Chronic Heart Failure (CHF), Iron Deficiency","enrollment":45},{"nctId":"NCT03214627","phase":"NA","title":"Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial","status":"TERMINATED","sponsor":"Vifor Fresenius Medical Care Renal Pharma","startDate":"2018-12-10","conditions":"Anemia, End Stage Renal Disease","enrollment":88},{"nctId":"NCT04016922","phase":"","title":"The Effect of Maternal Iron Deficiency Anemia on Fetal Hemodynamic and Neonatal Outcome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-07","conditions":"Fetal Conditions","enrollment":500},{"nctId":"NCT03917394","phase":"","title":"Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-04-24","conditions":"Anemia, Iron Deficiency","enrollment":780},{"nctId":"NCT02047552","phase":"PHASE2","title":"RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone","status":"WITHDRAWN","sponsor":"Denver Health and Hospital Authority","startDate":"2015-01","conditions":"Functional Iron Deficiency, Trauma, Anemia","enrollment":""},{"nctId":"NCT02731534","phase":"PHASE3","title":"Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2016-05","conditions":"Iron Deficiency Anemia","enrollment":238},{"nctId":"NCT00236951","phase":"PHASE3","title":"Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-02","conditions":"Anemia","enrollment":224},{"nctId":"NCT00721188","phase":"PHASE2","title":"Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-01","conditions":"Anemia","enrollment":11},{"nctId":"NCT01290315","phase":"PHASE2","title":"Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2009-08","conditions":"Iron Deficiency Anemia","enrollment":49},{"nctId":"NCT01180894","phase":"NA","title":"IV Iron for the Anemia of Traumatic Critical Illness","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2011-06","conditions":"Trauma, ICU Anemia","enrollment":150},{"nctId":"NCT01984554","phase":"","title":"Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-09","conditions":"Iron Deficiency Anemia (IDA)","enrollment":551},{"nctId":"NCT02009943","phase":"PHASE1","title":"Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill","status":"WITHDRAWN","sponsor":"Denver Health and Hospital Authority","startDate":"2017-02","conditions":"ICU Anemia, Functional Iron Deficiency","enrollment":""},{"nctId":"NCT00384657","phase":"PHASE3","title":"Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease","status":"WITHDRAWN","sponsor":"Anemia Working Group Romania","startDate":"2008-01","conditions":"Chronic Kidney Disease, Chronic Heart Failure, Anemia","enrollment":""},{"nctId":"NCT02787824","phase":"PHASE4","title":"Periodic Versus Continuous IV Iron Supplementation in HD Patients","status":"COMPLETED","sponsor":"Papageorgiou General Hospital","startDate":"2016-05","conditions":"Anemia of Chronic Kidney Disease","enrollment":27},{"nctId":"NCT03157050","phase":"","title":"Intravenous Iron May Increase Depression Among Hemodialysis Patients","status":"COMPLETED","sponsor":"Benha University","startDate":"2016-01-14","conditions":"Depression, Hemodialysis Complication, Iron Deficiency Anemia","enrollment":112},{"nctId":"NCT01857011","phase":"PHASE3","title":"Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2014-04","conditions":"Anemia, Iron-Deficiency, Weight Loss","enrollment":56},{"nctId":"NCT00830037","phase":"PHASE4","title":"A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease","status":"TERMINATED","sponsor":"Indiana University","startDate":"2008-08","conditions":"Chronic Kidney Disease, Iron-deficiency Anemia","enrollment":136},{"nctId":"NCT00318812","phase":"PHASE2, PHASE3","title":"Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-05","conditions":"Anemia, Renal Failure","enrollment":55},{"nctId":"NCT00660933","phase":"PHASE4","title":"Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2005-09","conditions":"Anemia, Puerperal Disorders","enrollment":70},{"nctId":"NCT01309659","phase":"PHASE2","title":"Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia","status":"TERMINATED","sponsor":"Duke University","startDate":"2011-05","conditions":"Anemia, Unexplained Anemia (UAE)","enrollment":19},{"nctId":"NCT01222884","phase":"PHASE3","title":"A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2011-06","conditions":"Chronic Kidney Disease Stage 5 (Dialysis Dependent)","enrollment":351},{"nctId":"NCT02392910","phase":"PHASE4","title":"Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.","status":"COMPLETED","sponsor":"Hospital Aleman","startDate":"2006-03","conditions":"Iron Deficiency, Heart Failure, Chronic Kidney Disease","enrollment":40},{"nctId":"NCT00746551","phase":"PHASE4","title":"Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2008-09","conditions":"Anemia, Pregnancy Complications","enrollment":80},{"nctId":"NCT00482716","phase":"PHASE3","title":"Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer","status":"UNKNOWN","sponsor":"St. Bartholomew's Hospital","startDate":"2007-01","conditions":"Anemia, Leukemia, Lymphoma","enrollment":80},{"nctId":"NCT01438372","phase":"PHASE2","title":"IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD","status":"WITHDRAWN","sponsor":"Wayne State University","startDate":"2011-11","conditions":"Iron Deficiency Anemia, Inflammatory Bowel Disease","enrollment":""},{"nctId":"NCT01443624","phase":"NA","title":"Evaluation of Oxidative Stress Induced by Iron Injection in Healthy Volunteers and Critical Care Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-10","conditions":"Critical Illness","enrollment":80},{"nctId":"NCT00560976","phase":"NA","title":"Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration","status":"UNKNOWN","sponsor":"Soroka University Medical Center","startDate":"2005-12","conditions":"Renal Failure Chronic Requiring Hemodialysis","enrollment":100},{"nctId":"NCT00224055","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":"Anemia, Iron-Deficiency, Kidney Failure, Chronic","enrollment":89},{"nctId":"NCT00224042","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":"Anemia, Iron-Deficiency, Kidney Failure, Chronic","enrollment":52},{"nctId":"NCT00534144","phase":"PHASE1","title":"Comparison Between Effects of Two Iron Preparations on Protein in the Urine","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2007-09","conditions":"Kidney Failure, Chronic, Anemia, Iron-Deficiency","enrollment":74},{"nctId":"NCT00661999","phase":"PHASE3","title":"Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-01","conditions":"Anemia, Leukemia, Lymphoma","enrollment":502},{"nctId":"NCT01078818","phase":"PHASE4","title":"Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation","status":"COMPLETED","sponsor":"Fundación Canaria Rafael Clavijo para la Investigación Biomédica","startDate":"2007-05","conditions":"Anaemia","enrollment":159},{"nctId":"NCT00308490","phase":"PHASE4","title":"Changes in Iron Markers Following Iron Loading in Hemodialysis Patients","status":"COMPLETED","sponsor":"Papageorgiou General Hospital","startDate":"2005-09","conditions":"Anemia in Chronic Renal Disease","enrollment":160},{"nctId":"NCT00386126","phase":"PHASE2, PHASE3","title":"Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2006-08","conditions":"Heart Failure, Anemia","enrollment":117},{"nctId":"NCT00204256","phase":"PHASE4","title":"Intravenous Iron in Patients With Anemia of Chronic Kidney Disease","status":"UNKNOWN","sponsor":"University Hospital Muenster","startDate":"2004-03","conditions":"Kidney Failure, Chronic","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CARDIAC FLUTTER"},{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"ENTEROCOLITIS"},{"count":1,"reaction":"FEBRILE NEUTROPENIA"},{"count":1,"reaction":"LOWER GASTROINTESTINAL HAEMORRHAGE"},{"count":1,"reaction":"PALPITATIONS"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Iron Sucrose injection"],"phase":"marketed","status":"active","brandName":"Iron Sucrose IV","genericName":"Iron Sucrose IV","companyName":"CN NGANOU-GNINDJIO, MD, MSc","companyId":"cn-nganou-gnindjio-md-msc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron sucrose is a stable iron-carbohydrate complex that delivers iron directly into the bloodstream to replenish iron stores and support hemoglobin synthesis. Used for Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in hemodialysis patients, Iron deficiency anemia in peritoneal dialysis patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}